SCHEMBL6002955

SCHEMBL6002955

[CH2]C(C)(C)c1cccc2nonc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ POLB P06746 2/20 0.39
▸ GFER P55789 1/20 0.39
▸ CASP1 P29466 2/20 0.39
▸ CASP7 P55210 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ ALDH1A1 P00352 6/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RECQL P46063 1/20 0.37
▸ LMNA P02545 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1104678 0.85 KMT2A (0.46) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL19040901 0.79 KMT2A (0.41) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL22023973 0.76 KMT2A (0.40) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL23597829 0.74 ALDH1A1 (0.39) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL23874215 0.73 KMT2A (0.37) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL21236222 0.71 ALDH1A1 (0.36) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL762439 0.70 KMT2A (0.65) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL13836119 0.70 KMT2A (0.46) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL1820230 0.70 KMT2A (0.46) KMT2AMAPK1L3MBTL1MEN1TDP1
SCHEMBL21577670 0.70 KMT2A (0.35) KMT2AMAPK1L3MBTL1MEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 — — EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 — — WO disclosed
Send feedback